Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Virax Biolabs Group

VRAX

VRAX Virax Biolabs Group NASDAQ
Add to watchlist
65.53
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    VRAX Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 1.60M
    • Turnover 105.04M
    • P/E(TTM) 25.46
    • Turnover % 1.14%
    • P/E(Static) 12.88
    • Market Cap 9.35B
    • P/B 5.72
    • Shares 142.64M
    • 52 Week Range
      52.99
      110.61
    • Day Range
      65.35
      66.35

    About

    Virax Biolabs Group Limited is a Cayman Islands exempted company incorporated on September 2, 2021. The company is a global innovative biotechnology group that primarily engages in sales, distribution and marketing of diagnostics test kits and med-tech and...
    • Highlight
      A provider of viral testing and diagnostic services primarily in the United States and Europe
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/21/2022
    • Established Date
      09/02/2021
    • Full-time Employees
      17
    • Address
      BioCity Glasgow Bo’Ness Road Newhouse Lanarkshire ML1 5UH United Kingdom
    • Tel
      44-20-77887414
    • Website
    • Fiscal Year End Date
      03/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD